3 累计需求单数
¥33,000.0 累计需求金额
0 违规次数

Enriching Low-Abundance Serum & Plasma Proteins

悬赏
未托管赏金
¥20000.00
  1. 发布需求
  2. 药智客交稿
  3. 任务主选稿中
  4. 验收与付款
  1. 任务结束
任务结束
交易模式:
单人中标
赏金分配:
一人独享赏金,¥20000
具体要求:
  Enriching Low-Abundance Serum & Plasma Proteins

  AWARD: $30,000 USD | DEADLINE: 10/01/11 | ACTIVE SOLVERS: 254 | POSTED: 8/01/11

  Source: InnoCentive Challenge ID: 9932714 Type: Theoretical-licensing

  Detailed Description & Requirements

  Concentrations of proteins in serum and plasma span up to 10 orders of magnitude – e.g. from serum albumin (50 mg/ml) to some cytokines and chemokines (<5 pg/ml)

  Protein molecules most useful to researchers exist at levels that are approximately at or below the 10,000 pg/ml range. Detection and quantification of these low-abundance proteins is obscured by the presence of high abundance proteins. Current methods for reducing the concentration of high-abundance proteins are either inefficient, targeted at certain proteins, or introduce bias and other artifacts.

  The Seeker is looking to identify novel methods to reliably reduce or eliminate high abundance proteins so that detection of protein analytes present at the 1-10 ng/ml scale or lower may be accurately detected.

  The Seeker envisages that a sample preparation techniques may be the most likely route to a solution. However, alternative approaches are also welcomed. The Seeker is highly experienced in sample preparation technologies for reduction of high-abundance proteins & is not interested in simple proposals of commercially available, or published, technologies and techniques.

  The Seeker is aware of the following ‘sample enrichment’ technologies for reducing the concentration of high abundance proteins from serum & plasma. The techniques are listed together with their limitations for the Seeker:

  Immunoaffinity depletions– depletions are extremely specific to the antigens the antibodies target. Commercially available kits commonly deplete 6-20 high abundance proteins with more than 90% efficiency. Although this enables detection of more low-abundance proteins, the column-based process induces some bias in low-abundance protein populations.

  Dye affinity depletions- Depletion of albumin using immobilized dyes such as Cibacron Blue. Limitations are that only albumin is depleted and proteins/peptides that interact with albumin are removed.

  Lectin affinity enrichments– low-abundance glycoproteins can be concentrated from serum/plasma using various lectin-binding procedures. Although efficient and specific, lectin enrichment introduces bias in the processed sample and results vary greatly depending on the techniques used.

  Peptide/nucleotide affinity reagents–methods based on interactions between abundant proteins and synthetic peptides or nucleotides (i.e. aptamers). Aptamers are fraught with non-specific and low affinity interactions and therefore are not desirable as a method of enrichment.

  The Seeker is not interested in a literature review and suggestions of possible techniques. Instead, the seeker requires a novel technology or technique that will dramatically (99.9% efficient) reduce, or eliminate, high abundance (>10 ng/ml) proteins from serum & plasma. Although a ‘universal’ solution is preferred, the Seeker is also interested in solutions that reduce or eliminate only certain classes of protein.

  Sample size and source is important – proposed technologies should be amenable to working with 50-1000 µl. Although human plasma and serum are the priority samples, the Seeker would ideally like to employ the successful technology on other mammalian sera and plasma.

  A ready-to-use method that offers good ease of use, efficacy and reproducibility is desired. However, the Seeker is willing to develop promising technologies and protocols in partnership with Seekers they judge suitable.

  Proposed solutions should fulfill the following Technical Requirements:

  1. Sample preparation technologies must:

  a. Be novel (not described in literature or commercially available)

  b. Be suitable for use with 50-1000 µl volumes

  c. Deplete high abundance proteins (>10 ng/ml) or large groups of proteins by 99.9% or more

  d. Not deplete or denature the low-abundance proteins. The Seeker is willing to accept some slight modification of low-abundance proteins or some bias in low-abundance proteins following the procedure. However, any bias or modification must be highly reproducible.

  2. Prepare sample that are:

  a. Depleted of proteins present at concentrations above 10 ng/ml

  b. Suitable for use in Mass Spectrometry

  3. The method should be adaptable for high throughput applications. Cost must not be prohibitive.

  Project Criteria

  This is a Theoretical Challenge that requires only a written proposal to be submitted.

  The submitted proposal should include the following:

  · A thorough description of the proposed method(s) or technologies & their mechanisms of action.

  · A listing of any specialized reagents or materials required, including suppliers if known

  · An extensive protocol for use of the technology or a roadmap for development of a suitable technology.

  · A list of the technologies limitations for the stated application.

  · A detailed explanations as to why Solver believes that the proposed solution meets the Requirements listed above. Literature references supporting the approach should be included.

  · Solvers who propose a solution similar to the methods listed above should include explanations as to how their proposed solution overcomes their limitations.

  · References to practical experience which a Solver may have in the field and an indication of the Solver’s availability to collaborate with the Seeker in developing a solution.

  The proposal should not include any personal identifying information (name, username, company, address, phone, email, personal website, resume, etc.)

  The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker.

  To receive an award, the Solvers will not have to transfer their exclusive IP rights to the Seeker. Instead, they will grant to the Seeker non-exclusive license to practice their solutions.

  应征稿件请直接上传到:https://www.innocentive.com
2011-09-06 10:37
0条新稿件,点击看看
  • jianglai

    这个任务也太难了吧,

    我来研究一下

    2011-09-22 13:17 参与编号 # 评论 举报
    数据载入中....
    发言请遵守"七条底线",还可以输入140个字

当前为付费需求,赏金分配方式:一人独享赏金。

任务主在众多备选稿件中选择最满意的稿件,支付赏金。

托管赏金,保障各方权益:

任务主把所发需求的悬赏金托管到药智网指定账户,以激发众多药智客的参与热情,保障任务主尽快征集到满意稿件;

同时,赏金托管也是为了保障参与挑战的药智客的正当权益。

流程说明:

发布需求

点击“发布需求”按钮,按照流程引导,将需求详情、具体要求描述清楚,发布到药智网的药智汇平台。

托管赏金

为征集到满意稿件,任务主须做好“赏金预算”,并将赏金托管到药智网指定账户,打消药智客的顾虑,激励药智客积极参与需求挑战。

药智客参与

任务主托管赏金后,所发布的需求显示“赏金已托管”字样。只有托管了悬赏金的需求,能够鼓舞众多的药智客参与,获取到满意的稿件!

选择满意稿件

任务主在众多参与者提交的稿件中,选择符合任务主需求的稿件。再通过互动,选择任务主最满意的稿件,并确定其为中标稿件。

验收与付款

中标稿件提交任务主验收。任务主在验收/验证期内,完成验收/验证工作。对合格稿件,通知药智网支付佣金。

评价

双方可以针对本次交易各自的表现进行评价,评价结果将影响各自的信用度和能力值。

类似的需求

    加载数据中...

该需求者还有这些需求

    加载数据中...

推荐需求

    加载数据中...
感兴趣,就投稿吧!投的越早,中标几率就越大! 收藏
扫一扫,关注药智汇微信
及时获得最新药智汇信息

2014 药智再发力 我们换装了!!

为了让您有更好的体验,药智对用户体系和产品进行了全新升级!

我要看看